Master One Thing - Rapamycin Longevity Series Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from two decades of Rapamycin research
May 15, 2023
Matt Kaeberlein, a leading Rapamycin researcher, discusses insights on mTOR, longevity, immune modulation, Dog Aging Project, effects on aging hallmarks, side effects of interventions, biomarkers for health assessment, personal experimentation, and future of longevity research.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12
Introduction
00:00 • 3min
Exploring the Role of mTOR Signaling in Lifespan Extension
02:46 • 15min
Rapa Myson's Impact on Aging Hallmarks
17:27 • 20min
The Immune Modulatory Effects of Rapamycin
37:27 • 17min
The Dog Aging Project: A Study on Companion Dogs
54:56 • 6min
Impact of Feeding Frequency on Age-Related Diseases in Dogs
01:00:49 • 29min
Exploring Side Effects in Longevity Interventions
01:30:18 • 7min
Analysis of Various Biomarkers for Assessing Future Health and Biological Aging
01:37:15 • 5min
Personal Rapamycin Experimentation
01:41:56 • 13min
Longevity Interventions and Research Evolution
01:54:30 • 15min
Exploring Rapamycin and mTOR Inhibition
02:09:23 • 15min
Future Plans in Science-Based Longevity and Preventative Medicine
02:24:42 • 4min